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INTRODUCTION
The term “supraorganism” (which we pre-
fer to the more common but slightly less
informative “superorganism”) refers to a
collection of individuals which behave as a
single unit with enhanced function. It was
originally applied to groups of genetically-
identical individuals such as social insect
colonies (Moritz and Fuchs, 1998), but
has since been expanded to include sys-
tems comprised of taxonomically-diverse
species from all domains of life, as well
as viruses (Salvucci, 2012). The human
intestine plays host to up to 1014 bacte-
ria, which outnumber the host’s own cells
by around an order of magnitude: micro-
bial concentrations in the colon can reach
1012 cells per gram. There are also large
numbers of viruses, predominantly bac-
teriophages, with at least 109 viral par-
ticles present per gram of human feces.
Current evidence presents a picture of pre-
vailing homoeostasis between host, micro-
biome and virome consistent with the
description of a supraorganism, which can
nevertheless enter a disrupted alternative
state termed “dysbiosis.” Here we review
this evidence and the potential for the
adoption of supra-organismal approaches
toward the treatment and prevention of




The adult gastrointestinal (GI) tract har-
bors a vast and diverse population of
microorganisms comprised of ∼1014 indi-
viduals with a total genetic potential
some two orders of magnitude larger
than the host (Sommer and Bäckhed,
2013). Anaerobic Bacteria dominate this
microbial community, which also includes
aerobic or facultatively anaerobic Bacteria,
Archaea, and Eukaryota, alongside a large
but much more poorly-defined viral com-
munity (see below). Despite its diver-
sity, the bacterial community comprises
only a small subset of known phyla,
suggesting strong selection of species
adapted to the host environment and
geared to a neutral or mutually-beneficial
relationship with the host (Turnbaugh
et al., 2009; The Human Microbiome
Project Consortium, 2012). The phyla
Firmicutes and Bacteroidetes dominate
the gut microbiome, with members of
the Proteobacteria, Actinobacteria, and
Fusobacteria also abundant. The coloniza-
tion of the infant GI tract begins at birth
and initiates with facultatively anaerobic
Proteobacteria, due to the initially oxidiz-
ing environment; anaerobic Bacteroidetes,
Actinobacteria, and Firmicutes colonize
later, and the microbiome composition
stabilizes and begins to resemble that of
the adult between 1 and 2 years of age
(Sekirov et al., 2010).
That the gut microbiome is of immense
benefit to its human host is attested to
by its plethora of interactions through-
out development (Figure 1), as well as the
negative consequences of its disruption
in dysbiosis (Walker and Lawley, 2013).
Lederberg (2000) was the first to appreci-
ate that the microbiome constitutes part
of the human “self” in supraorganism the-
ory. The best-defined contribution of the
microbiota of the GI tract is a metabolic
one: these microorganisms have a com-
bined metabolic capacity equivalent to
that of the liver, justifying their description
as an additional human organ (Gill et al.,
2006; Sommer and Bäckhed, 2013). Their
key metabolic roles include the breakdown
of otherwise indigestible polysaccharides
into readily-absorbed short-chain fatty
acids (SCFAs), the production of essential
vitamins and other metabolites and the
detoxification of harmful substances
(Walker and Lawley, 2013). These activi-
ties all complement the host metabolism,
expanding its functional capacity with-
out the need for additional host-encoded
genetic potential, while the other side of
the mutualistic relationship is the constant
temperature and nutrient-rich environ-
ment afforded to the microbiota by the
host. The microbiota also plays a role
in the metabolic phenotypes associated
with diseases such as obesity: genetically
obese (ob/ob) mice contain increased lev-
els of SCFAs in their cecum, and their
microbiota has an increased content of
genes involved in polysaccharide degra-
dation compared to that of lean mice
(Tremaroli and Bäckhed, 2012), an obser-
vation replicated in humans (Turnbaugh
et al., 2009). Even more strikingly, trans-
plantation of the microbiota from an
obese donor mouse to a germ-free recip-
ient causes the recipient to gain fat at
twice the level of a mouse transplanted
with the microbiota from a lean donor
(Turnbaugh et al., 2006), confirming
that the microbiome can actively deter-
mine the phenotypic response of the
host rather than merely responding pas-
sively to dietary intake. Furthermore,
recipients transplanted with an “obese”
microbiota fail to develop the obese phe-
notype if co-housed with mice harboring
a “lean” microbiota. This phenomenon
is associated with the transfer of spe-
cific Bacteroidetes species from the lean
microbiota to the obese, but is depen-
dent upon diet (Ridaura et al., 2013).
There is therefore a complex interaction
between host genome, microbiota, and
environment in which all three com-
ponents can play a controlling role
(Figure 1).
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FIGURE 1 | Interactions between the human host, the intestinal
microbiome, and the virome. Functional effects of a normal intestinal
microbiome are illustrated, together with the bi-directional interactions
between the microbiome and virome, and between the GI tract and brain via
the microbiome. The panels at the right show the perturbations associated
with various altered microbiome states: the germ-free state in laboratory
mice, obesity in mice and humans, and human dysbiosis. Increased
parameters are shown with yellow shading and upward-pointing arrows;
reduced parameters are shown with red shading and downward-pointing
arrows.
The gut microbiome begins to assem-
ble from birth and matures alongside the
host immune system; it might therefore
be expected to contribute significantly
to the development of that system. The
intestine is a unique, high-surface area,
super-densely populated bioreactor with
permeable walls which must retain bio-
logical integrity—the acquisition of an
immune system which can tolerate the
beneficial microbiota while responding
effectively to pathogens must have been a
crucial step in the evolution of the result-
ing supraorganism. This has led to the
proposal that the adaptive immune system
of vertebrates may have evolved to man-
age the complex communities of beneficial
microorganisms found in their GI tracts,
in contrast to the innate immunity and
either very simple or well-contained
microbiota of invertebrates (McFall-Ngai,
2007). Presumably this gave vertebrates
the advantage of greater digestive flexibil-
ity, perhaps at the cost of susceptibility to
autoimmunity. It is certainly true that the
majority of the interactions of the immune
system involve tolerance of the beneficial
microbiota rather than antagonism toward
pathogens (Arrietta and Finlay, 2012).
Germ-free mice show underdevelopment
of the gut-associated lymphoid tissue
(GALT), altered differentiation of immune
cell subtypes and an abnormal intesti-
nal mucus layer which can be restored
by treatment with bacterial lipopolysac-
charide or peptidoglycan (Sommer and
Bäckhed, 2013). The interaction between
the immune system and the microbiota
is therefore one of mutual reinforcement
rather than top-down control (Figure 1).
Finally, the effects of the gut micro-
biome extend well beyond the GI tract
itself. One emerging field is the inter-
action between intestinal microbiota
and the brain via the so-called “gut-
brain axis” (Collins et al., 2012). Such
interactions include effects of gut micro-
biota on the levels of brain signaling
molecules, dysbiosis-induced increase
in anxiety-related behavior in mice,
correspondingly reduced anxiety in germ-
free mice (Sommer and Bäckhed, 2013)
and a co-occurrence of psychiatric disor-
ders with dysbioses such as irritable bowel
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syndrome (Hsiao et al., 2013). Therefore,
bacterial by-products affect the brain
directly or via endocrine cells or cytokines,
while brain-derived hormones or neuro-
transmitters modulate the microbiota via
gut physiology or influences on bacterial
signaling and gene expression (Collins
et al., 2012). These observations support a
wider model in which the gut microbiota
is an integrated component of the human
body, with multiple, wide-ranging, and
bi-directional interactions with many of
its other components (Figure 1).
A SUPRA-ORGANISMAL VIROME?
Viral abundance and diversity outnum-
bers that of bacteria in most ecosys-
tems yet, with a few notable exceptions
(Dinsdale et al., 2008), its characterization
lags behind that of cellular microorgan-
isms. The vast majority of viruses are bac-
teriophages which target prokaryotic cells,
and much work on their effects on struc-
turing the microbiota has been performed
in marine systems. These studies suggest
that bacteriophages have a major effect
by targeting the fastest-growing bacterial
species (the “Kill the Winner” hypoth-
esis; Thingstad, 2000), causing a drastic
restructuring of the microbial commu-
nity (Bouvier and el Giorgio, 2007) and
increasing its diversity (Hewson et al.,
2003) by a process akin to negative
frequency-dependent selection (Ayala and
Campbell, 1974). However, studies of the
human gut virome suggest that rather
different bacterial-phage dynamics may
exist therein. Although the virome shows
greater interpersonal variation than the
corresponding microbiome, intrapersonal
diversity is low [a∼1:1 ratio of virotypes to
bacterial phylotypes, compared to 10:1 in
marine systems (Reyes et al., 2010)], virus
particles and bacterial cells are present
in similar numbers and most dominant
virotypes are temporally stable and exhibit
a temperate (non-lytic) lifestyle (Figure 1;
Reyes et al., 2012). Such temporal vari-
ation as exists is largely restricted to
lytic bacteriophages such as Microviridae,
which evolve rapidly (>10−5 substitutions
nucleotide−1 day−1), giving divergence of
a level equivalent to the definition of novel
viral species over a 2.5-year period (Minot
et al., 2013). It is likely that a combi-
nation of bacterial strain-specific selec-
tion, long-term stability of the majority
of the selected virome and rapid evo-
lution of the remainder gives rise to
the extreme interpersonal variability of
the gut virome. More significantly, we
propose that the contrast between the
Lotka-Volterra dynamics of virus-bacteria
interactions in marine systems and the
apparent co-adaptation of the virome in
the gut is indicative of a stronger supra-
organismal organization in the latter.
The contribution of phage-encoded
genes to bacterially-mediated ecosys-
tem functions is well-documented in
marine systems. Cyanophages infect-
ing Prochlorococcus and Synechococcus
species carry key functional genes, such as
those encoding photosystem components,
which can increase bacterial primary pro-
duction (Rohwer and Thurber, 2009).
Comparable effects of the gut virome on
host function via virally-encoded genetic
or metabolic potential are less clear-cut.
Many of the best-defined examples are
virulence factors, such as the phage 933W
Shiga-like toxin (Plunkett et al., 1999),
which assist invasion of the normal micro-
biota by bacterial pathogens; viruses are
also implicated in the global spread of
antibiotic-resistance genes via horizon-
tal gene transfer (Smillie et al., 2011).
However, there are indications that the
virome may carry beneficial intestinal
functions to host bacteria, such as the
observation of many genes for anaerobic
metabolism in fecally-derived viral contigs
(Reyes et al., 2010) and the potential for
modification of bacterial carbohydrate uti-
lization via phage receptors (Reyes et al.,
2012).
The gut virome of healthy individu-
als is massively dominated by bacterio-
phages, with eukaryotic virus sequences
either undetectable or at very low levels
(Minot et al., 2013). However, significant
occurrences of eukaryotic enteroviruses
are particularly associated with the host
disease andmicrobiome disruption of dys-
biosis, as discussed below.
HOST-MICROBIOME-VIROME
INTERACTIONS AND DYSBIOSIS
“Dysbiosis” is a rather poorly-defined
term which is generally taken to mean
a severe compositional disruption of the
(intestinal) microbiota usually associated
with an effect on host health (Walker and
Lawley, 2013). It is characterized by a
decline in microbial diversity and in the
prevalence of obligate anaerobes belong-
ing to the Firmicutes phylum, often asso-
ciated with a decline in Bacteroidetes
and an increase in facultatively-anaerobic
Proteobacteria. Known causes include
infection with pathogens of the GI tract,
broad-spectrum antibiotic treatment and
host-initiated disruptions such as colorec-
tal cancer (Walker and Lawley, 2013),
but distinguishing between a causal and
responsive role for the microbiome in con-
ditions such as Crohn’s disease and ulcera-
tive colitis (UC) is often difficult.
Both analysis and, potentially, treat-
ment of dysbiosis can benefit from a
supra-organismal approach. Apart from
the obvious host disruption caused
by diarrhea, microbiome-dependent
metabolic functions such as SCFA pro-
duction are adversely affected in dysbiosis,
and this can in turn exacerbate diar-
rhea and contribute toward chronic
inflammation (Ramakrishna and Mathan,
1993). Inflammation and disruption
of the epithelial mucosal barrier prob-
ably themselves prolong dysbiosis by
favoring the attachment and survival of
Enterobacteriaceae over anti-inflammatory
Firmicutes species (Willing et al., 2011).
The eukaryotic virome can also be
involved in the onset and/or mainte-
nance of dysbiosis: diarrhea caused by
agents such as adenovirus, norovirus, and
rotavirus is associated with microbiomes
of reduced diversity, reduced Bacteroidetes
levels and increased Proteobacteria (Ma
et al., 2011; Nelson et al., 2012). There is
therefore a complex set of causative and
downstream interactions leading to the
persistence of the dysbiotic state in the
intestinal supra-organism (Figure 1).
There has been much recent interest
in the use of microbiota transplantation,
typically using healthy donor feces, to
treat intestinal dysbiosis (Palmer, 2011).
As well as clinical demonstrations of
this approach in patients with recur-
rent Clostridium difficile infection and UC
(Walker and Lawley, 2013), experiments in
mouse models demonstrate that it is an
effective way of re-establishing a healthy
microbiome in dysbiotic animals which
is resistant to subsequent challenge with
pathogens (Lawley et al., 2012). The excit-
ing prospect of using the bacteriophage
components of the virome to structure a
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healthy microbiome and promote benefi-
cial functions such as nutrient biosynthesis
(Reyes et al., 2012) would be a logical
extension of such an approach to dysbiosis
treatment. Our rapidly-expanding knowl-
edge of the supra-organism defined by the
host intestine, its microbiome and virome
should enable us to turn the possibility
of such therapies into reality in the com-
ing years. Moreover, the general approach
of linking our knowledge of this supra-
organism to ecological concepts relating
to homoeostasis and the modulation of
a habitat by its resident organisms (Jones
et al., 1994; Odling-Smee et al., 2003; Dyke
and Weaver, 2013) will be beneficial for
our understanding of the ecosystem state
changes in the GI tract that we can now
monitor so readily.
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